Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Faster Trial Planning and Site Selection
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.
Using Technology To Reduce Monitoring Costs And Increase Quality
Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.
Closing The Gaps: Strengthening Safety Data Flow In Outsourced Clinical Trials
Outsourced clinical trials risk safety missteps when communication falters. Clear, detailed data flow processes help prevent lost context, reduce misclassification, and support more accurate safety decisions across CROs and internal teams.
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.

Tips And Tricks For Developing Rare Cancer Clinical Trials
2/6/2025

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
Quotient Sciences Capacity Update July 2025
7/29/2025

Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.
Vendor Selection Bias: Why Structured Decisions Often Fail
12/22/2025

Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
A Guide To Patient Reimbursements And Payments
9/13/2024

Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.
Expedite Drug Development With An Integrated CDMO-CRO Model
2/6/2026

From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.

Drug-Drug Interaction (DDI) Studies

Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
Enabling Research At Speed And Scale For Maximal Impact

Our turnkey operational infrastructure empowers sponsors and partners to execute trials more efficiently — reducing costs, accelerating timelines, and consistently delivering high-quality data.
An Introductory Guide To Clinical EU Qualified Person (QP) Services

PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
Regulatory Consultancy Services

Global Strategies to Align Your Goals With Regulatory Requirements

Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.